SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : STEM -- StemCells, Inc.
STEM 16.67+1.0%Nov 14 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: cl who wrote (25)2/20/1997 10:45:00 PM
From: Miljenko Zuanic   of 805
 
Thanks Chuck. Still one things is not clear to me. Intellectual property-conflict of interest between NXCO and Cognetix. Dr. Olivera has several patents on natural conotoxin peptides (omega included). The earliest one is P#4,447,356 (1984)-broad coverage of conotoxins. NXCO develop library of amino acid sequence modified conotoxins (conopeptides)-SNX. There are possibility of patent litigation between Dr.Olivera (University of Utah) and NXCO.

Miljenko
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext